Home

Sequent Scientific Ltd EPS

Image

Sequent Scientific Ltd

NSE: SEQUENT

EPS

₹ 0.51

Last updated on: May 16, 2025

Key Highlights

  • The Earning per Share of Sequent Scientific Ltd is ₹ 0.51 as of 16 May 25 .
  • The earning per share of Sequent Scientific Ltd changed from ₹ -1.4 to ₹ 0.14 over 7 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Sequent Scientific Ltd

No data available

* All values are in

Company Fundamentals for Sequent Scientific Ltd

Market Cap

4,570 Cr

EPS

0.5

P/E Ratio (TTM)

358.0

P/B Ratio (TTM)

6.7

Day’s High

186.1

Day’s Low

170.85

DTE

0.7

ROE

2.9

52 Week High

240.9

52 Week Low

91.85

ROCE

7.4

Market Price of Sequent Scientific Ltd

1M

1Y

3Y

5Y

Monitoring Sequent Scientific Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
16 May 2025182.6
15 May 2025176.15
14 May 2025174.35
13 May 2025167.85
12 May 2025168.75
09 May 2025160.85
08 May 2025155.25
07 May 2025153.25
06 May 2025153.5
05 May 2025156.35

SWOT Analysis Of Sequent Scientific Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Sequent Scientific Ltd

Asset Value vs Market Value of Sequent Scientific Ltd

Market Value

4,571

Asset Value

Value addition

4.1 X

891

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Sequent Scientific Ltd4570
Sun Pharmaceutical Industries Ltd416273
Divis Laboratories Ltd166750
Cipla Ltd121122
Torrent Pharmaceuticals Ltd110482
Mankind Pharma Ltd105963

Historical Market Cap of Sequent Scientific Ltd

No data available

* All values are in crore

Historical Revenue of Sequent Scientific Ltd

No data available

* All values are in crore

Historical EBITDA of Sequent Scientific Ltd

No data available

* All values are in crore

Historical Net Profit of Sequent Scientific Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sequent Scientific Ltd News Hub

Sequent Scientific receives WHO prequalification approval for Albendazole API

Sequent Scientific announced its receipt of prequalification (PQ) approval from the World Health Org

Read more

20 Aug 24

Sequent Scientific hits 52-week high after receiving prequalification approval for Albendazole

This is in partnership with Mepro Pharmaceuticals, who have successfully developed and commercialise

Read more

20 Aug 24

Sequent Scientific reports consolidated net profit of Rs 6.51 crore in the June 2024 quarter

Net profit of Sequent Scientific reported to Rs 6.51 crore in the quarter ended June 2024 as against

Read more

16 Aug 24

Sequent Scientific to table results

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 14 August 2024. P

Read more

09 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sequent Scientific Ltd

What is the EPS of Sequent Scientific Ltd stock?

The Earnings Per Share (EPS) of Sequent Scientific Ltd is 0.51. An EPS is the amount of net income attributed to each share of a common stock.

How is Sequent Scientific Ltd EPS calculated?

The EPS of Sequent Scientific Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sequent Scientific Ltd report its EPS?

Sequent Scientific Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sequent Scientific Ltd EPS?

Factors that influence the EPS of Sequent Scientific Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sequent Scientific Ltd EPS growth indicate future performance?

Yes, consistent growth in Sequent Scientific Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions